LSTR
Landstar System, Inc.
LSTR has lower modeled downside risk, despite its lower overall score.
VRT
Vertiv Holdings Co
VRT has the edge over LSTR overall, supported by stronger valuation and stronger fundamentals.
LSTR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Strong |
LSTR's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
LSTR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $73.63 | -50% |
| Forward | 20x | $148 | — |
| Fair | 26x | $122 | -18% |
| Current | 31x | $148 | — |
| Expensive | 32x | $152 | +2.6% |
Historical ranges are pointers, not guarantees.
LSTR's PE is in its expensive range at 31x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over LSTR in the historical PE scenario, which offers more potential upside but is not a forecast.
LSTR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for LSTR, with profitability holding steady. However, they disagree widely on these estimates.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
VRT has the edge over LSTR on the outlook, with more favorable profitability expectations.
LSTR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.23 | +53% |
| Q3 2026 | $4.72 | +21% |
| Q2 2026 | $3.86 | -19% |
| Q1 2026 | $3.62 | -28% |
| Q4 2025 | $3.31 | -40% |
| Q3 2025 | $3.91 | -33% |
| Q2 2025 | $4.76 | -22% |
| Q1 2025 | $5.04 | -23% |
| Q4 2024 | $5.51 | -25% |
LSTR's earnings per share have fallen from their peak: $4.72 over the past year, against $12.14 in late 2022.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over LSTR on earnings, with more consistent year-over-year improvement.
LSTR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +25% |
| Q2 2026 | $1.4B | +18% |
| Q1 2026 | $1.2B | +1.6% |
| Q4 2025 | $1.2B | -2.9% |
| Q3 2025 | $1.2B | -0.7% |
| Q2 2025 | $1.2B | -1.1% |
| Q1 2025 | $1.2B | -1.6% |
| Q4 2024 | $1.2B | +0.4% |
LSTR's revenue is recovering but still below its 2022 peak: $1.5B last quarter, up 25% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.3% | +2.2 points |
| Q2 2026 | 4.6% | 0 points |
| Q1 2026 | 4.5% | +1.1 points |
| Q4 2025 | 2.5% | -2.3 points |
| Q3 2025 | 2.2% | -3 points |
| Q2 2025 | 4.7% | -0.9 points |
| Q1 2025 | 3.4% | -1.7 points |
| Q4 2024 | 4.8% | -1.4 points |
LSTR's operating margin was 4.3% last quarter, up 2.2 points from the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over LSTR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over LSTR on profitability, with a higher operating margin.
LSTR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $68M | -21% |
| Q2 2026 | -$53.3M | -1245% |
| Q1 2026 | $72.4M | +35% |
| Q4 2025 | $70.5M | +30% |
| Q3 2025 | $86M | +14% |
| Q2 2025 | $4.7M | -89% |
| Q1 2025 | $53.8M | -37% |
| Q4 2024 | $54.4M | -32% |
LSTR still generates free cash flow, though less than at its 2022 peak: $158M over the past year.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over LSTR on cash flow, with more consistent year-over-year improvement.
LSTR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.2x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -1.7x | Net Cash |
| Q4 2025 | -2.0x | Net Cash |
| Q3 2025 | -1.6x | Net Cash |
| Q2 2025 | -1.3x | Net Cash |
| Q1 2025 | -1.5x | Net Cash |
| Q4 2024 | -1.7x | Net Cash |
LSTR has the edge over VRT on leverage, with a lower net debt burden relative to earnings.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has more cash than debt.
LSTR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.0 | Neutral |
| Stochastic | 13.1 | Oversold |
LSTR's weekly RSI is 37 (neutral) and its Stochastic is 13 (oversold).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
LSTR PE vs Industrials Sector
| Metric | LSTR | Sector median | Relative |
|---|---|---|---|
| PE | 31x | 24x | 31% above |
| PE % | 82 | 58 | 24 pts above |
LSTR has the edge over VRT on valuation relative to its sector.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
LSTR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $159.7 | 7.3% below |
| 20 week MA | $177.1 | 16% below |
| 50 week MA | $171.9 | 14% below |
| 100 week MA | $157.1 | 5.8% below |
| 200 week MA | $170.3 | 13% below |
LSTR is in a downtrend: it's below all five of its weekly moving averages, and 13% below its 200-week average.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has the edge over LSTR on trend strength, trading above more of its moving averages.
LSTR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $113.2 | $135.4 | +20% |
| 2021 | $135.4 | $172.2 | +27% |
| 2022 | $172.2 | $166.5 | -3.4% |
| 2023 | $166.5 | $193.7 | +16% |
| 2024 | $193.7 | $174.3 | -10% |
| 2025 | $174.3 | $146.0 | -16% |
| 2026 YTD | $146.0 | $148.0 | +1.4% |
LSTR has finished lower in three of the last six years. It's up 1.4% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over LSTR on returns for 2026, with the stronger performance.